Health Facility Drug Diversion: Essential Compliance & Auditing Measures
|
|
|
- Janice McKinney
- 10 years ago
- Views:
Transcription
1 Health Facility Drug Diversion: Essential Compliance & Auditing Measures Kimberly S. New JD BSN RN Kelly C. Loya CPC-I, CHC, CPhT, CRMA
2 Discussion Topics Diversion defined Scope of the problem Profile and predisposing factors Impact on the patient and institution Reporting requirements Components of a diversion prevention, detection and response program Auditing & Prevention Diversion Case Study
3 Hello Who is our audience?
4 Drug Diversion What is it? How big is the problem?
5 Diversion Defined Diversion: The use of prescription drugs for recreational purposes. Diverting a prescription drug for other than its intended purpose. Addiction: Continued use despite harm
6 Healthcare Facility Drug Diversion Theft of medication, including waste, from patients or health care facilities for personal use
7 Scheduled Drugs Developed by The Controlled Substances Act of 1970 Currently there are 5 Schedules Schedule I: no accepted medical use, high potential for abuse. Example: heroin, ecstasy Schedule II: accepted medical use with severe restrictions with high potential for abuse. Example: cocaine, morphine Schedule III: accepted medical use with moderate to low potential for abuse. Example: codeine, vicodin Schedule IV: accepted medical use with potential for abuse, but less than Schedule III. Example: valium, ambien Schedule V: accepted medical use with low potential for abuse. Example: Robitussin AC State and local laws may be more restrictive
8 The Facts Reliable statistics on the prevalence of drug diversion by nurses are not available By its nature, diversion is a clandestine activity, and methods in place in many institutions leave cases undiscovered or unreported Drug diversion by health care providers is universal among institutions in the United States If your institution is not finding and reporting drug diversion, review your program with the goal of identifying its weak points
9 Who and Why? Occupational factors Suppression of feelings and emotions Vicarious trauma Physical demands of job Legitimate use and chronic pain Ease of access to prescriptions and medication Knowledge and sense of control The major factors impacting the incidence of drug misuse by healthcare professionals are access and availability of controlled substances. Bell DM, McDonough JP, Ellison JS, Fitzhugh ED. Controlled drug misuse by Certified Registered Nurse Anesthetists. AANA J 1999;67(2):
10 Who and Why? Profile High achiever Significant stress in personal life Night shift Critical care or other unit where nursing staff have increased autonomy Agency Legitimate prescription for drug being diverted Smoker
11 Our Experience Approximately 1 nurse per month Award winners New Grads Team Leaders Pediatric and neonatal nurses Pregnant nurses Clusters of nurses
12 Impact on Patients Impairment and addiction put patients at risk Strong likelihood of denying patients appropriate pain relief Potential to expose patients to bloodborne pathogens Falsification of records (fraud) Theft
13 Tampering Boulder Community Hospital Over 300 potential victims Sentenced to 54 months in federal prison followed by 3 years Ashton Paul Daigle supervised release Rose Medical Center Over 20 patients infected Plea bargain rejected, sentenced to 30 years Kristin Parker
14 Tampering Exeter Hospital 8 states 3,798 tested from Exeter alone 44 cases of hepatitis C David Kwiatkowski St Cloud Hospital - Siphoned fentanyl from IV bags Replaced fentanyl with saline 24 patients infected with bacteria
15 Recognition of Patient Harm Diversion doesn t always result in patient harm, but beware of these situations: Diversion of scheduled (non prn) doses Documentation of pain at the time medication is diverted Evidence of substitution and tampering, including transmission of infection Impairment resulting in patient harm or reckless endangerment
16 Impact on Institution Liability-civil, regulatory Negative publicity License and participation in Medicare/Medicaid in jeopardy Hospitals are required to be in compliance with the Federal requirements set forth in the Medicare Conditions of Participation (CoP) in order to receive Medicare/Medicaid payment. State Operations Manual Appendix A - Survey Protocol, Regulations and Interpretive Guidelines for Hospitals
17 DEA 21 CFR Employee screening procedures. (Non-practitioners) DEA position that obtaining certain information by non-practitioners is vital to assess the likelihood of an employee committing a drug security breach Need to know is a matter of business necessity, essential to overall controlled substances security Conviction of crimes and unauthorized use of controlled substances are activities that are proper subjects for inquiry
18 DEA 21 CFR Illicit activities by employees Employees who possess, sell, use or divert controlled substances will subject themselves not only to State or Federal prosecution Employer will immediately determine status of continued employment by assessing the seriousness of the violation, the position of responsibility held by the employee, past record of employment, etc.
19 Conditions of Participation (c)(2) - The patient has the right to receive care in a safe setting Hospital must: Protect vulnerable patients Identify and evaluate problems and patterns of incidents
20 Conditions of Participation (a)(3) - Current and accurate records must be kept of the receipt and disposition of all scheduled drugs Records of all scheduled drugs must be maintained and any discrepancies in count reconciled promptly Must be capable of quickly identifying loss or diversion of controlled substances and determining the extent of the diversion Must have policies and procedures in place which minimize scheduled drug diversion
21 Conditions of Participation (b)(2)(i-ii) - All drugs and biologicals must be kept in a secure area, and locked when appropriate Storage procedures must prevent unmonitored access by unauthorized individuals Mobile nursing medication carts, anesthesia carts, epidural carts and other medication carts containing Schedule II, III, IV, and V drugs must be locked within a secure area If tampering or diversion occurs, or if medication security otherwise becomes a problem, the hospital must evaluate its current medication control policies and procedures, and implement the necessary systems and processes to ensure that the problem is corrected, and that patient health and safety are maintained
22 The Joint Commission The hospital must safely: Manage high alert medications Store medications Control medications brought from home Dispense and administer medications Manage returned medications and The hospital must evaluate the effectiveness of medication management system
23 Reporting
24 Reporting Controlled Substance Loss Three agencies place responsibility for security of all drugs in the healthcare setting on the Pharmacy Drug Enforcement Agency ( The Joint Commission ( American Society of Health-System Pharmacists ( Each state has a Pharmacy State Board that has a number of regulatory requirements
25 Reporting Is Essential Must report to DEA immediately State Licensure Board and/or Professional Assistance Law Enforcement - crimes, issues of abuse/neglect/reckless endangerment, fraud Pharmacy Board FDA/OCI (tampering cases) OIG
26 DEA 21 CFR Employee responsibility to report drug diversion Reports of drug diversion are necessary part of employee security program but also serve the public interest at large An employee who has knowledge of drug diversion from his employer by a fellow employee has an obligation to report such information to a responsible security official of the employer
27 Conditions of Participation (b)(7) - Abuses and losses of controlled substances must be reported, in accordance with applicable Federal and State laws, to the individual responsible for the pharmaceutical service, and to the chief executive officer, as appropriate Controlled drug losses must be reported to DEA Some states mandate reporting of a crime or drug related crime
28 Getting Help Most states have an alternative program to assist in the rehabilitation of impaired healthcare professionals Law enforcement may use generic wording if an arrest is made and a treatment in lieu of conviction program may be offered Failing to report is not the compassionate approach
29 Why Don t We Hear More? Fear of negative publicity Fear of State and Federal agency involvement Uncertainty about reporting requirements and avenues Justification that terminating the employee is enough
30 Consequences Diverter is dismissed/employment terminated or allowed to quit Potential of rehabilitation near zero Violates laws and regulations Disregards the well being of the diverter No reported history will bypass preventive screening at next employer
31 Internal Controls Components of a diversion prevention, detection and response program
32 Internal Controls Preventive* Detective Automated Manual First Do No Harm Internal Control Failure Can Lead to Diversion Most common Purchasing/Inventory Wasting/Overrides Point of Care
33 Not at My Hospital! Denial is common Diversion can happen anywhere Where you least expect it From those who you may least suspect Internal Controls protect The facility The employee The patient
34 Inventory Management Audit Procedures Policies and procedures Review & develop tests of controls Human Resources and/or Law Department referenced related to loss or theft Policies regarding random drug testing of employees with controlled substance access Criminal background checks for potential of employees with controlled substance access
35 Inventory Management Audit Procedures Automated dispensing systems (cont) Physical controls Location of workstations & accessibility by non users Computer screens locked when not in use Automated Medication Unit Security Passwords Unsuccessful Log Ons Limited User Access Default Sign Off Reports with User ID Listed
36 Inventory Management Audit Procedures Specific controlled substance security Schedule II must be locked at all times Schedule III V may be dispensed throughout non-controlled stock Analysis of dispensing, override and waste reports General physical security Cameras Alarm System Panic Buttons Physical Floor Plan Employee Identification Terminated Employee Process
37 Inventory Management Audit Inventory counts Procedures Conduct a count of a sample of controlled substances with a pharmacy representative present Note expiration dates and how products are stored (by date) Review sample of Significant loss of controlled substances DEA Form-106 (breakage & spillage does not apply) Observe disposal and waste procedures for controlled substances Identify outdated stock procedures and inventory of items returned/destroyed
38 Inventory Management Audit Procedures Segregation of duties for following processes Primary storage for controlled substances Ordering controlled substances Purchase requisitions Purchase orders Receiving report Invoice processing Control procedures Physical inventory Dispensing Ordering Receipt Authorization/ Payment No one person should be given control of a related function
39 10 minute ~Break~
40 Recognizing Diversion Activity
41 Essential Components of Diversion Prevention and Detection Program Policies to prevent, detect and properly report diversion Collaborative relationship between nursing and pharmacy Method of surveillance/auditing including concurrent review of medical records Prompt attention to surveillance data received Collaborative relationship with law enforcement and regulatory agencies Education, education and education
42 Recognition of Diversion Hospitals may have automated drug cabinets that produce data about controlled substance transactions, but many diversion schemes can t be detected this way. Personal observation is vital! It may be the only clue.
43 Education Most essential component of any diversion program! All-inclusive At hire and at least annually Emphasize recognition and reporting Goal Develop a culture in which employees recognize the risks and feel individual responsibility for reporting
44 Education Tailor to audience Clinical Staff and Managers: Methods of Diversion (Managers) Behavioral Clues Physical Signs of Opioid Abuse How to Use Automated Data Make it real-use actual cases and examples
45 Compromised Vials
46 Recognition of Diversion/Impairment Tardiness, unscheduled absences and an excessive number of sick days used; Frequent disappearances from the work site and taking frequent or long trips to the bathroom or to the stockroom where drugs are kept; Volunteers for overtime and is at work when not scheduled to be there; Arrives at work early and stay late; Pattern of removal of controlled substances near or at end of shift;
47 Recognition of Diversion/Impairment Work performance alternates between periods of high and low productivity, may suffer from mistakes, poor judgment and bad decisions; Interpersonal relations with colleagues, staff and patients suffer. Rarely admits errors or accepts blame for errors or oversights (denial); Insistence on personal administration of injected narcotics to patients; Heavy or no "wastage" of drugs; and Pattern of holding waste until oncoming shift.
48 Signs of Opioid Abuse Physical Constricted pupils Itching/Scratching Sweating Chills Runny nose Vomiting/Diarrhea Anorexia Tracks Behavioral Malaise/Fatigue Euphoria Anxiety Insomnia Depression Apathy Paranoia
49 Program Structure Diversion Committee - multidisciplinary Diversion Response Team (including go to person ) Diversion Risk Rounds (unannounced and at least quarterly)
50 Monitor for Risks!
51 Auditing
52 Policies and Procedures Pre-employment screening Drug handling Surveillance Reasonable suspicion drug testing Suspected diversion Confirmed diversion, including internal and external reporting
53 Understanding the Technology RN signs on with unique username and password RN selects the patient, drug desired and quantity Single bin is unlocked and nurse required to key in the quantity present before removal 2 users required for waste or return
54 Drug Cabinet
55 Single Access Bin
56 Wasting Injectable CS
57 Injectables: Hydromorphone Fentanyl Propofol Pills and liquids: Hydrocodone Oxycodone Drugs of Choice
58 Surveillance Technology Many hospitals have surveillance technology Not as common in long term care facilities Provides flags and reveals issues to focus on Many selective reports can be run when doing an investigation
59 Daily Surveillance Data All transactions for each user Discrepancies in the count Staff that are statistically significant when compared to their peers in withdrawals of a scheduled drug Instances in which a drug was removed without a recognized order (medication override) Drugs removed in large quantities Drugs removed in close time proximity Drugs removed for discharged patients
60 Methods of Diversion Removal of medication when not needed Often initial method of diversion Very difficult to detect Falsification of records Removal for discharged patient Removal of duplicate dose May not be caring for patient May be preceptor Removal of/diversion from fentanyl patches Removal of gel with syringe and needle Keeping new patch for self and putting used patch on patient
61 Removal When Not Needed
62 Withdrawal for Discharged Patient
63 Duplicate Dose
64 Duplicate Dose
65 Removal of Duplicate Dose
66 Methods of Diversion Removal of medication without order Medication override Falsification of verbal order Removal and use from inconspicuous vessel
67 Medication Overrides
68 False Verbal Order
69 Methods of Diversion Failure to waste Unwasted medication kept for self (proper waste procedure is to waste upon removing whenever possible) Frequent wasting of entire doses (should be returned) Substitution in administration and wasting Substitution of look-alike pills Saline substituted for injectable medication Potential for tampering charges
70 Frequent Wasting
71 Auditing Technology allows for optimal tracking of: Purchasing Inventory controls Dispensing Wastage Patient Administration Pain Control and Clinical Analysis Medication Errors Technology alone is not the silver bullet Policy/Procedures with Education/Training Accountability Monitoring/Tracking Detection and Prevention of Inventory Loss
72 Monitoring Suspicious Activity A single suspicious transaction may be easily explained Watch for a pattern of activity Consider using a watch list An intensified review may be warranted before you are sure (i.e., review of all transactions)
73 Auditing Who are you protecting? The organization s reputation The patient Family and Friends The care givers With all this technology, what is the risk? More sophisticated, more creative tactics More harm Tools often under-utilized Lack of awareness Off the shelf instillation Lack of reporting Poor understanding of clinical processes
74 Auditing What can we do? Learn more about the system used Understand the capabilities of reporting Use data to report regularly Share the information to monitor Require reporting and follow through Involve IT Support
75 Auditing Investigate the system What are the recommended settings for the system used? Understand the programming What functions are on? What is available that is off? Why is it off? (This better be good!) Understand the end user s view Who authorizes access? What are the settings on access? What are the different access levels? How do these differ in different care areas? Who can override? Who can waste? What authorization is needed?
76 Auditing
77 Auditing Desk Review Current Policies and Procedures Are they current? Work-Arounds? Previous DEA Form 106 s Report of Theft or Loss of Controlled Substances Completed DEA form 41 s Registrants Inventory of Drugs Surrendered Used in the disposal or destruction of a controlled substance Past purchase orders DEA form 222 s DEA Controlled Substance Order Form Must be used when Schedule I and II are bought, sold or transferred between qualified parties Data Reports Management Report Monitoring Utilization Reports
78 Common Areas of Weakness Lack of internal controls over controlled substances stored in emergency kits for trauma or urgent needs Pain response documentation not regularly reviewed for patterns Inadequate segregation of duties End user passwords not changed per hospital policy End users not terminated from system Job changes/responsibilities Termination Discharged patient list remaining available for hours after DC Drug testing Not done at pre-employment screening Not performed randomly for staff with access Staff with no or little training/competency on system (poor practices) Built in System controls turned off - too cumbersome
79 Auditing Data Cancelled Transactions Report Discrepancies Overrides Medication Wastage Include in reports: End User name Workstation/Patient Care Area Medication Date and Time of transaction
80 Auditing Data Reviewing the Report Data: Unusual or high patterns of: Wastage Overrides Patterns of wasting partners Time of transaction patterns Volumes of administration at unexpected levels based on patient care area Uneven administration to one patient or groups of patients in one area Floating nurses with higher than area administration averages, waste, discrepancies and/or override functions
81 Auditing Process Survey Controlled Substance areas Pharmacy Medication Rooms Job shadowing Pharmacy Pharmacists Techs ( Account Number ) Clinicians in Patient Care Areas Nurses Physicians Mid-Level Staff (NP, PA who have access) Operative Procedures Pre-op OR Post op
82 Auditing Interview What processes are used? Have they been trained? How often? Proper segregation of duties? Are there back up to staff who perform critical functions? Challenge their knowledge Staff know where weaknesses are Don t fail to ask the obvious questions
83 DIVERSION INVESTIGATIONS
84 When Diversion Suspected Diversion team put on alert Verification of data and analysis of situation Nurse immediately removed from patient contact or intercepted; drug cabinet access discontinued Initial interview of nurse including review of medical record and drug cabinet records Urine drug screen Suspension pending conclusion of investigation
85 Drug Screen 12 Panel Amphetamines Cannabinoids Opiates Propoxophene Alcohol Barbiturates Cocaine Oxcodone/oxymorphone Meperidene Benzodiazepines Methadone Phencyclidene Add fentanyl, zolpidem and others as required
86 Drug Screen Avoid tip-off! Make sure drug screen is observed and be familiar with testing service and ordering requirements ahead of time!
87 Diversion confirmed Determine employment disposition Report to law enforcement and all relevant state and federal agencies Consider billing implications and rebill if necessary Assist and educate law enforcement and other agencies involved in investigating or prosecuting case Notify patients if applicable
88 Actual Diversion Investigation 8/9/12-PD placed on watch list for bulk wasting
89 Diversion Investigation January 2013-daily surveillance reveals resumed bulk wasting
90 Diversion Investigation February 2013-received alert that PD flagged on Pandora Anomalous Usage report for hydromorphone
91 Diversion Investigation Review of recent transactions-patient comatose and on hydromorphone drip. No one else administering hydromorphone except PD.
92 Diversion Investigation PD asks for one time orders for hydromorphone extremely often Even if patient is on morphine or another CS, PD asks doctor to change order to hydromorphone PD only one administering hydromorphone to many of her patients PD always administers oral Opioid with hydromorphone if one is ordered
93 Diversion Investigation Run report comparing her to her peers on hydromorphone usage
94 Diversion Investigation Nurse manager questions staff re: comatose patient Call PD in to meet with her: Huge delay Allow PD to explain- I medicate my patients UDS-dilute Suspension
95 Diversion Investigation Expanded review of her transactions mg of Dilaudid identified as missing via failure to waste One Percocet 10/325 was also missing Test her story Not statistically significant and way below peers on all other CS on her transaction report Occurrence report check-no issues
96 Diversion Investigation Removing Dilaudid doses when there isn t any pain documented Removing Dilaudid doses when there isn t an order (in anticipation of getting one) Wasting entire syringes of Dilaudid but returning other CS not used Dividing one time Dilaudid doses so that more than one syringe can be obtained Failing to waste Dilaudid Requesting orders for Dilaudid when other medications patient was already on not tried Bulk wasting Dilaudid Delayed wasting of Dilaudid Wasting more Dilaudid than she withdrew and documenting administration of medication when none was obtained (wasting is obviously lax if someone is witnessing this or she is substituting syringes) Documenting pain scores inconsistent with colleagues (i.e., two Percocet per day for several days, and then on her 2 consecutive shifts patient gets 5 doses of Percocet and 5 doses of Dilaudid) Giving implausible excuses for pulling Dilaudid and not administering ( may be discharged today ) Documenting administration of IV Dilaudid at time of and after discharge Administering Dilaudid to patients for whom it is not appropriate
97 Diversion Investigation Report missing medication to DEA Report to TBI and KPD Report to Professional Assistance and Board of Nursing Report to Pharmacy Board Spreadsheet to billing to rebill those with missing medication
98 Pharmacy diversions continue to increase. Investigations will continue to be a hot topic Organizations have a DUTY to ensure the safety of their patients AND their staff. Organizations have a MUST be certain the quality of care provided remains uncompromised. Early detection and prevention is the KEY to changing behaviors.
99 Thank you! Kimberly New, JD BSN RN (865) Copyright 2013 Kim New ALL RIGHTS RESERVED Kelly C. Loya, CPC-I, CHC, CPhT, CRMA (704)
How To Prevent A Drug Diversion
Institutional Diversion Prevention, Detection and Response Kimberly S. New JD BSN RN Discussion Points Scope of the problem External authorities Impact on the patient and institution Diversion prevention,
How to Develop a Diversion Program Kimberly New JD BSN RN National Association of Drug Diversion Investigators
1 How to Develop a Diversion Program Kimberly New JD BSN RN National Association of Drug Diversion Investigators AHIA 32 nd Annual Conference August 25-28, 2013 Chicago, Illinois www.ahia.org Discussion
Southlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
NOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
Arkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
(Updated: 10/12/2015)
DRUG TESTING & BACKGROUND CHECK Pfizer s Drug Testing and Background Check Requirements for Contingent Workers and Suppliers, Including Criminal and MVR Record Checks, FDA Debarment Database and DEA Controlled
CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS
CIINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD HEALTH CARE PROFESSIONAL INVESTIGATIONS CINCINNATI POLICE PHARMACEUTICAL DIVERSION SQUAD Kelly Raker 310 Ezzard Charles Dr. Cincinnati, OH 45214 513-564-2233
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
Patient Safety. Road Map to Controlled Substance Diversion Prevention
Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/
What Parents Need to Know
What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to
Drug-Free Workplace Policy and Procedures July 16, 2015
Drug-Free Workplace Policy and Procedures July 16, 2015 Regional Transit Authority of Southeast Michigan Drug-Free Workplace Policy and Procedures Purpose In compliance with regulations governing anti-drug
How To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
What You Need to Know About Substance Use Disorder in Nursing
What You Need to Know About Substance Use Disorder in Nursing Facts about Substance Use Disorder Substance use disorder encompasses a pattern of behaviors that range from misuse to dependency or addiction,
ARKANSAS. Downloaded January 2011
ARKANSAS Downloaded January 2011 302 GENERAL ADMINISTRATION 302.11 Pharmacies operated in nursing homes shall be operated in compliance with Arkansas laws and shall be subject to inspection by personnel
Opioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
Drug Diversion in Healthcare
Drug Diversion in Healthcare By Barry Abramowitz Drug abuse in America continues to grow. In 2012, approximately 23.9 million Americans used illicit drugs. Of these, 6.8 million used prescription drugs
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In
Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs
Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility Nancy Lamb RPh Good Day Pharmacy DEA- Drug Enforcement Administration This is not the State Health Department
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
What Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
STATE OF FLORIDA DEPARTMENT OF HEALTH ORDER OF EMERGENCY SUSPENSION OF LICENSE. H. Frank Farmer, Jr., MD, PhD, FACP, State Surgeon General, ORDERS the
Final Order No. DOH-I I -2297-6%6A FILED DATE 'actk Department of Health STATE OF FLORIDA DEPARTMENT OF HEALTH Deputy Agency Clerk In Re: Emergency Suspension of the License of ORDER OF EMERGENCY SUSPENSION
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
Ambulatory Surgical Centers Frequently Asked Questions
Ambulatory Surgical Centers Frequently Asked Questions Index Top General Definitions Compliance with State Licensure Laws Governing Body and Management Surgical Services Quality Assessment and Performance
Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
Urine Drug Testing Methadone 101 Methadone for hospitalists
Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug
Opioid Overdose Prevention Guidelines for Training Responders
Opioid Overdose Prevention Guidelines for Training Responders Oct 31, 2006 OD Oct 31, 2006 Opioid Overdose Prevention Guidelines for Training Responders BACKGROUND Introduction Opioid overdose is a serious
CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
Controlled substances Identifying risks and internal audit focus areas
Controlled substances Identifying risks and internal audit focus areas Introduction With a mission focused on improving the health of patients and taking care of the sick, health care providers face unique
POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL
PURPOSE POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL To outline the procedures used in recognizing and providing
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids
UW School of Dentistry Comprehensive Medication Policy
UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides
A Multidisciplinary Approach to Proactive Drug Diversion Prevention
A Multidisciplinary Approach to Proactive Drug Diversion Prevention Jerry Siegel Pharm.D. FASHP Sr. Director, Pharmaceutical Services The Ohio State University Medical Center Columbus, Ohio October 1,
Methadone Maintenance Treatment for Opioid Dependence
COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO P O L I C Y S TAT E M E N T # 2 1 0 Methadone Maintenance Treatment for Opioid Dependence APPROVED BY COUNCIL: PUBLICATION DATE: KEY WORDS: REFERENCE MATERIALS:
DHHS POLICIES AND PROCEDURES
DHHS POLICIES AND PROCEDURES Section V: Human Resources Current Effective Date: 9/1/11 Revision History: 7/1/03, 4/1/04; 4/6/09; 9/1/11 Original Effective Date: 8/1/89 Purpose The purpose is to establish
Drug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
Cincinnati Christian University Drug Abuse Prevention Program
Cincinnati Christian University Drug Abuse Prevention Program Cincinnati Christian University maintains that our bodies are created by God and should be used to glorify Him. The misuse or abuse of alcohol
OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program
Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department
Renaissance Academy Charter School
Renaissance Academy Charter School SECTION: TITLE: NO: 227 Pupils Drug and Alcohol Usage 1 st READING: May 11, 2006 2 nd READING: ADOPTED: June 12, 2006 REVISED: October, 10, 2010 ADOPTED: December 10,
ADMINISTRATION OF MEDICATION
ADMINISTRATION OF MEDICATION IN SCHOOLS MARYLAND STATE SCHOOL HEALTH SERVICES GUIDELINE JANUARY 2006 (Reference Updated March 2015) Maryland State Department of Education Maryland Department of Health
RULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER 1200-34-01 PAIN MANAGEMENT CLINICS TABLE OF CONTENTS
RULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER 1200-34-01 PAIN MANAGEMENT CLINICS TABLE OF CONTENTS 1200-34-01-.01 Purpose 1200-34-01-.06 Notifications 1200-34-01-.02 Definitions
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
Policies & Procedures
2.2 Drug Free Work Place Adopted 1.24.2003 Revised 3.28.2004; 5.26.2006; 3.2.2011 Reference: WAC 388.805.200(3) POLICY In accordance with "The Drug Free Workplace Act of 1988, The Healing Lodge prohibits
Greater Altoona Career & Technology Center ADULT EDUCATION DRUG & ALCOHOL POLICY
The Greater Altoona Career & Technology Center recognizes that the abuse of controlled substances is a serious problem with legal, physical and social implications for the whole school community. As an
PHARMACY SECURITY BEST PRACTICES
CHRIS CHRISTIE Governor KIM GUADAGNO Lt. Governor Division of Consumer Affairs Office of the Director 124 Halsey Street, 7 th Floor, Newark NJ PHARMACY SECURITY BEST PRACTICES Published May 1, 2013 New
Information for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
POLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE
POLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE I. STATEMENT OF PURPOSE Crossroads of Western Iowa recognizes the problems of substance abuse in society and in the workplace. Substance abuse poses a serious
CHARLES & SUE S SCHOOL OF HAIR DESIGN DRUG AND ALCOHOL POLICY DRUG AND ALCOHOL POLICY; SUBSTANCE ABUSE RESOURCES:
CHARLES & SUE S SCHOOL OF HAIR DESIGN DRUG AND ALCOHOL POLICY DRUG AND ALCOHOL POLICY; SUBSTANCE ABUSE RESOURCES: At Charles & Sue s School of Hair Design, the illicit use of drugs and/or alcohol by staff
Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules
D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy
MOSAIC DES MOINES Alcohol/Drug Free Workplace Policy Purpose: To help safeguard employee health, provide a safe and productive workplace, and supply our people served with high quality service, Mosaic
INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People
Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory
Good Practice Guidance: The safe management of controlled drugs in care homes
Good Practice Guidance: The safe management of controlled drugs in care homes Medicines Management Social Care Support Team Reviewed April 2015 Good Practice Guidance: The safe management of controlled
Application Fee Explanation
Certified Registered Nurse Anesthetist (CRNA) Information License Required You must hold a current, valid Oregon Certified Registered Nurse Anesthetist license before you practice as a CRNA sign your name,
Controlled Substance Diversion: Tales from the Front
Controlled Substance Diversion: Tales from the Front Jim Jorgenson, RPh, MS, FASHP VP, Chief Pharmacy Officer Clarian Health Partners/Indiana University Health Indianapolis, IN Objectives Understand the
1) ELIGIBLE DISCIPLINES
PRACTITIONER S APPLICABLE TO ALL INDIVIDUAL NETWORK PARTICIPANTS AND APPLICANTS FOR THE PREFERRED PAYMENT PLAN NETWORK, MEDI-PAK ADVANTAGE PFFS NETWORK AND MEDI-PAK ADVANTAGE LPPO NETWORK. 1) ELIGIBLE
Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
NEW YORK STATE MEDICAID FRAUD CONTROL UNIT Eric T. Schneiderman Attorney General of the State of New York
NEW YORK STATE MEDICAID FRAUD CONTROL UNIT Eric T. Schneiderman Attorney General of the State of New York Jennifer M. Sommers Special Assistant Attorney General Medicaid Fraud Control Unit Created in 1975
Iowa Governor s Office of Drug Control Policy
Talking to kids about {prescription drug abuse Iowa Governor s Office of Drug Control Policy Talking to kids about {prescription drug abuse As a parent you re concerned about your children s health and
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
Practice Protocol. Buprenorphine Guidance Protocol
Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol
Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
UCSD Controlled Substances Program Procedures
UCSD Controlled Substances Program Procedures I. PROCEDURE A. Controlled Substance Use Authorization Requirements A Controlled Substance Use Authorization (CSUA) must be completed prior to acquiring controlled
Fraud, Waste and Abuse
Fraud, Waste and Abuse CT - Fraud Hotline submitted by Connecticut The Fraud Hotline at the Department of Social Services (DSS) is a proactive approach to handling complaints regarding fraud and abuse
12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
Pharmacy Program Pre-Test
Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group
PRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
EXHIBIT A. GRIEVANCE FORM (use additional sheets where necessary) STEP ONE EMPLOYER S STEP ONE RESPONSE STEP TWO
EXHIBIT A GRIEVANCE FORM (use additional sheets where necessary) Filed: Department: Village of Freeburg Public Works Grievant s Name: Last First M.I. STEP ONE of Incident or Knew of Facts Giving Rise to
Identity Theft Prevention Program Compliance Model
September 29, 2008 State Rural Water Association Identity Theft Prevention Program Compliance Model Contact your State Rural Water Association www.nrwa.org Ed Thomas, Senior Environmental Engineer All
Policy Rationale and Text
Policy Title: Impaired Resident Physicians Original Date: July 2010 GMEC Endorsed: April 2015 Next Revision Date: April 2017 David C. Weigle, PhD, MPH Assistant Dean for Graduate Medical Education Designated
New Provider Guidance for Medication Administration
New Provider Guidance for Medication Administration Transcript Title Slide (no narration) Webcast Tips There are a few things that will assist you in navigating through the webcast. At the bottom of the
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS
105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription
Overall Learning Objectives
Overall Learning Objectives Understand the difference between use, misuse and abuse of substances/drugs; Differentiate between commonly abused legal and illegal substances/drugs; Become aware of common
Visit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options
In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.
Administrative Policy
Administrative Policy Number: 411 Effective: 4/7/2011 Supersedes: n/a Page: 1 of 8 Subject: Use of Controlled Substances in Research 1.0. PURPOSE: The purpose of this policy is to set forth procedures
Wyoming STATE BOARD OF NURSING
Matthew H Mead Governor Wyoming STATE BOARD OF NURSING Mary Kay Goetter, PhD, RNC, NEA-BC Executive Director 1810 Pioneer Avenue Cheyenne, Wyoming 82002 Phone: 307-777-7601 FAX: 307-777-3519 http://nursing.state.wy.us
To ensure compliance with State and Federal mandated reporting requirements. To ensure appropriate documentation of significant events.
Vermont State Hospital Policy Mandatory Reporting Policy Replaces version dated: 1/20/10 Updated X Effective Date: 3/04/10 Approved by the Commissioner of the Department of Mental Health: Date: 1/20/10
OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION
1.0 Purpose OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION This is a DESC internal operational policy and procedure document [effective date: 06/26/2015] Greg Jensen, Director of Administrative Services
IN THE THIRD DISTRICT COURT IN AND FOR SALT LAKE COUNTY SALT LAKE DEPARTMENT, STATE OF UTAH : : : : : : : : :
SEAN D. REYES, Attorney General (7969) LANA TAYLOR, Assistant Attorney General (7642) WAYNE D. JONES, Assistant Attorney General (7235) Attorneys for the State of Utah 5272 South College Dive, Suite 200
Pharmacy Law Overview. From Civil Liability to Criminal Prosecution
Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 [email protected] Pharmacy
A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death
A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE
2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013
Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
SAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
BLINN COLLEGE ADMINISTRATIVE POLICY/PROCEDURE MANUAL
BLINN COLLEGE ADMINISTRATIVE POLICY/PROCEDURE MANUAL SUBJECT: Athletic Department Drug EFFECTIVE DATE: 9-14-10 Testing Policy and Procedure REVISION DATE: 8-28-12 The Blinn College Administration and the
WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE DRUG AWARENESS AND PREVENTION PROGRAM PURPOSE
WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE DRUG AWARENESS AND PREVENTION PROGRAM PURPOSE The West Virginia School of Osteopathic Medicine recognizes the importance of a safe, healthy and efficient work
3341-7-09 Use of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
